Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,976,728
  • Shares Outstanding, K 208,050
  • Annual Sales, $ 3,723 M
  • Annual Income, $ 722,200 K
  • 60-Month Beta 0.91
  • Price/Sales 10.11
  • Price/Cash Flow 34.98
  • Price/Book 12.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.33
  • Number of Estimates 10
  • High Estimate 1.37
  • Low Estimate 1.30
  • Prior Year 1.24
  • Growth Rate Est. (year over year) +7.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
172.14 +2.67%
on 04/18/19
193.96 -8.88%
on 04/01/19
-12.67 (-6.69%)
since 03/25/19
3-Month
163.08 +8.37%
on 02/01/19
197.86 -10.68%
on 03/18/19
+6.09 (+3.57%)
since 01/25/19
52-Week
127.29 +38.84%
on 04/30/18
197.86 -10.68%
on 03/18/19
+47.21 (+36.45%)
since 04/25/18

Most Recent Stories

More News
Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised

Edwards Lifesciences (EW) gains on strong segmental contributions in Q1.

EW : 176.49 (-0.70%)
BIO : 293.06 (-0.25%)
XRAY : 49.82 (-1.15%)
ICUI : 223.87 (-1.76%)
Edwards Lifesciences: 1Q Earnings Snapshot

IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported first-quarter earnings of $249.7 million.

EW : 176.49 (-0.70%)
Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter...

EW : 176.49 (-0.70%)
Edwards Lifesciences Takes Over CAS Medical Systems for $100M

This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.

EW : 176.49 (-0.70%)
AMED : 124.91 (+1.08%)
VAR : 131.56 (-1.28%)
PEN : 133.61 (+0.19%)
So Far, So Good for Earnings Season

So Far, So Good for Earnings Season

EW : 176.49 (-0.70%)
ZM : 64.83 (+2.58%)
HEXO : 7.16 (+0.42%)
SLGN : 29.81 (+0.47%)
GWPH : 159.65 (-0.86%)
CNC : 49.58 (-1.24%)
PINS : 27.97 (+4.37%)
Edwards Lifesciences Completes Acquisition of CASMED

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the completion of its acquisition...

EW : 176.49 (-0.70%)
CASM : 2.45 (+0.41%)
Neovasc Announces Resolution of Last Remaining Active Litigation

NASDAQ, TSX: NVCN

EW : 176.49 (-0.70%)
NVCN : 0.50 (-3.85%)
NVCN.TO : 0.65 (-9.72%)
After Yesterday's Decline of 4.63%, Edwards Life Offers Investors Better Value

Edwards Life (NYSE:EW) traded in a range yesterday that spanned from a low of $181.57 to a high of $189.71. Yesterday, the shares fell 4.6%, which took the trading range below the 3-day low of $188.55...

EW : 176.49 (-0.70%)
What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?

Edwards Lifesciences (EW) expects to gain from core Critical Care product group in Q1.

EW : 176.49 (-0.70%)
SYK : 185.79 (+0.41%)
CAH : 46.67 (+0.19%)
PKI : 94.25 (-0.29%)
Top 5 Companies in the Health Care Equipment Industry with the Best Relative Performance (HRC , ATRC , EW , DXCM , NUVA )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

EW : 176.49 (-0.70%)
HRC : 96.26 (+0.02%)
ATRC : 28.12 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade EW with:

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 185.24
1st Resistance Point 181.49
Last Price 176.49
1st Support Level 173.49
2nd Support Level 169.24

See More

52-Week High 197.86
Last Price 176.49
Fibonacci 61.8% 170.90
Fibonacci 50% 162.57
Fibonacci 38.2% 154.25
52-Week Low 127.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar